nodes	percent_of_prediction	percent_of_DWPC	metapath
Desogestrel—Cataract—Vandetanib—thyroid cancer	0.0278	0.0451	CcSEcCtD
Desogestrel—PGR—Nuclear Receptors—THRB—thyroid cancer	0.0272	0.0709	CbGpPWpGaD
Desogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—KRT19—thyroid cancer	0.0249	0.0648	CbGpPWpGaD
Desogestrel—Neoplasm—Vandetanib—thyroid cancer	0.0239	0.0388	CcSEcCtD
Desogestrel—PGR—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.0215	0.056	CbGpPWpGaD
Desogestrel—Neoplasm—Sorafenib—thyroid cancer	0.0161	0.0262	CcSEcCtD
Desogestrel—ESR1—Nuclear Receptors—THRB—thyroid cancer	0.016	0.0416	CbGpPWpGaD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CITED1—thyroid cancer	0.0159	0.0415	CbGpPWpGaD
Desogestrel—Erythema nodosum—Epirubicin—thyroid cancer	0.0153	0.0248	CcSEcCtD
Desogestrel—Weight decreased—Vandetanib—thyroid cancer	0.015	0.0244	CcSEcCtD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.0147	0.0384	CbGpPWpGaD
Desogestrel—Erythema nodosum—Doxorubicin—thyroid cancer	0.0141	0.0229	CcSEcCtD
Desogestrel—ESR1—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.0126	0.0329	CbGpPWpGaD
Desogestrel—Erythema multiforme—Vandetanib—thyroid cancer	0.0126	0.0204	CcSEcCtD
Desogestrel—Eye disorder—Vandetanib—thyroid cancer	0.0124	0.0202	CcSEcCtD
Desogestrel—Mood swings—Sorafenib—thyroid cancer	0.0123	0.0199	CcSEcCtD
Desogestrel—Alopecia—Vandetanib—thyroid cancer	0.0117	0.0191	CcSEcCtD
Desogestrel—Breast disorder—Sorafenib—thyroid cancer	0.0117	0.019	CcSEcCtD
Desogestrel—Mental disorder—Vandetanib—thyroid cancer	0.0116	0.0189	CcSEcCtD
Desogestrel—Malnutrition—Vandetanib—thyroid cancer	0.0116	0.0188	CcSEcCtD
Desogestrel—PGR—Nuclear Receptors—RXRA—thyroid cancer	0.0116	0.0301	CbGpPWpGaD
Desogestrel—Vaginal discharge—Epirubicin—thyroid cancer	0.0108	0.0176	CcSEcCtD
Desogestrel—Weight decreased—Sorafenib—thyroid cancer	0.0101	0.0164	CcSEcCtD
Desogestrel—Vaginal discharge—Doxorubicin—thyroid cancer	0.01	0.0163	CcSEcCtD
Desogestrel—Hypertension—Vandetanib—thyroid cancer	0.00999	0.0162	CcSEcCtD
Desogestrel—PGR—Nuclear signaling by ERBB4—NRG1—thyroid cancer	0.00978	0.0255	CbGpPWpGaD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00978	0.0159	CcSEcCtD
Desogestrel—SHBG—Nongenotropic Androgen signaling—HRAS—thyroid cancer	0.00946	0.0247	CbGpPWpGaD
Desogestrel—Nervous system disorder—Vandetanib—thyroid cancer	0.00926	0.015	CcSEcCtD
Desogestrel—Skin disorder—Vandetanib—thyroid cancer	0.00917	0.0149	CcSEcCtD
Desogestrel—PGR—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00913	0.0238	CbGpPWpGaD
Desogestrel—Erythema multiforme—Sorafenib—thyroid cancer	0.00848	0.0138	CcSEcCtD
Desogestrel—SHBG—Nongenotropic Androgen signaling—AKT1—thyroid cancer	0.00835	0.0218	CbGpPWpGaD
Desogestrel—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00815	0.0132	CcSEcCtD
Desogestrel—Immune system disorder—Sorafenib—thyroid cancer	0.0081	0.0131	CcSEcCtD
Desogestrel—Alopecia—Sorafenib—thyroid cancer	0.00792	0.0129	CcSEcCtD
Desogestrel—Mental disorder—Sorafenib—thyroid cancer	0.00786	0.0127	CcSEcCtD
Desogestrel—Malnutrition—Sorafenib—thyroid cancer	0.00781	0.0127	CcSEcCtD
Desogestrel—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00772	0.0125	CcSEcCtD
Desogestrel—Breast pain—Epirubicin—thyroid cancer	0.00756	0.0123	CcSEcCtD
Desogestrel—Abdominal pain—Vandetanib—thyroid cancer	0.00747	0.0121	CcSEcCtD
Desogestrel—PGR—Nuclear Receptors—PPARG—thyroid cancer	0.00729	0.019	CbGpPWpGaD
Desogestrel—Breast pain—Doxorubicin—thyroid cancer	0.007	0.0114	CcSEcCtD
Desogestrel—ESR1—Nuclear Receptors—RXRA—thyroid cancer	0.00678	0.0177	CbGpPWpGaD
Desogestrel—ESR1—FOXM1 transcription factor network—CDK1—thyroid cancer	0.00674	0.0176	CbGpPWpGaD
Desogestrel—Hypertension—Sorafenib—thyroid cancer	0.00674	0.0109	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.0066	0.0107	CcSEcCtD
Desogestrel—Diarrhoea—Vandetanib—thyroid cancer	0.00646	0.0105	CcSEcCtD
Desogestrel—Fluid retention—Epirubicin—thyroid cancer	0.00627	0.0102	CcSEcCtD
Desogestrel—Nervous system disorder—Sorafenib—thyroid cancer	0.00625	0.0101	CcSEcCtD
Desogestrel—ESR1—Estrogen signaling pathway—BRAF—thyroid cancer	0.00623	0.0162	CbGpPWpGaD
Desogestrel—Skin disorder—Sorafenib—thyroid cancer	0.00619	0.01	CcSEcCtD
Desogestrel—Vomiting—Vandetanib—thyroid cancer	0.00601	0.00974	CcSEcCtD
Desogestrel—Neoplasm—Epirubicin—thyroid cancer	0.00597	0.00968	CcSEcCtD
Desogestrel—Rash—Vandetanib—thyroid cancer	0.00596	0.00966	CcSEcCtD
Desogestrel—Dermatitis—Vandetanib—thyroid cancer	0.00595	0.00965	CcSEcCtD
Desogestrel—Headache—Vandetanib—thyroid cancer	0.00592	0.0096	CcSEcCtD
Desogestrel—Fluid retention—Doxorubicin—thyroid cancer	0.0058	0.0094	CcSEcCtD
Desogestrel—PGR—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00576	0.015	CbGpPWpGaD
Desogestrel—ESR1—Nuclear signaling by ERBB4—NRG1—thyroid cancer	0.00574	0.015	CbGpPWpGaD
Desogestrel—Nausea—Vandetanib—thyroid cancer	0.00561	0.0091	CcSEcCtD
Desogestrel—Neoplasm—Doxorubicin—thyroid cancer	0.00552	0.00896	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.0055	0.00892	CcSEcCtD
Desogestrel—ESR1—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00536	0.014	CbGpPWpGaD
Desogestrel—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00521	0.00845	CcSEcCtD
Desogestrel—PGR—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00513	0.0134	CbGpPWpGaD
Desogestrel—Urticaria—Sorafenib—thyroid cancer	0.00506	0.00821	CcSEcCtD
Desogestrel—Abdominal pain—Sorafenib—thyroid cancer	0.00504	0.00817	CcSEcCtD
Desogestrel—Migraine—Epirubicin—thyroid cancer	0.00472	0.00765	CcSEcCtD
Desogestrel—Affect lability—Epirubicin—thyroid cancer	0.00472	0.00765	CcSEcCtD
Desogestrel—Hypersensitivity—Sorafenib—thyroid cancer	0.00469	0.00761	CcSEcCtD
Desogestrel—Mood swings—Epirubicin—thyroid cancer	0.00454	0.00736	CcSEcCtD
Desogestrel—ESR1—AP-1 transcription factor network—CDK1—thyroid cancer	0.00448	0.0117	CbGpPWpGaD
Desogestrel—Affect lability—Doxorubicin—thyroid cancer	0.00436	0.00708	CcSEcCtD
Desogestrel—Migraine—Doxorubicin—thyroid cancer	0.00436	0.00708	CcSEcCtD
Desogestrel—Diarrhoea—Sorafenib—thyroid cancer	0.00436	0.00707	CcSEcCtD
Desogestrel—Breast disorder—Epirubicin—thyroid cancer	0.00433	0.00702	CcSEcCtD
Desogestrel—ESR1—Nuclear Receptors—PPARG—thyroid cancer	0.00428	0.0112	CbGpPWpGaD
Desogestrel—Mood swings—Doxorubicin—thyroid cancer	0.0042	0.00681	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—CDK1—thyroid cancer	0.00411	0.0107	CbGpPWpGaD
Desogestrel—Vomiting—Sorafenib—thyroid cancer	0.00405	0.00657	CcSEcCtD
Desogestrel—Rash—Sorafenib—thyroid cancer	0.00402	0.00652	CcSEcCtD
Desogestrel—Dermatitis—Sorafenib—thyroid cancer	0.00401	0.00651	CcSEcCtD
Desogestrel—Breast disorder—Doxorubicin—thyroid cancer	0.00401	0.0065	CcSEcCtD
Desogestrel—Headache—Sorafenib—thyroid cancer	0.00399	0.00647	CcSEcCtD
Desogestrel—Nausea—Sorafenib—thyroid cancer	0.00378	0.00614	CcSEcCtD
Desogestrel—Weight increased—Epirubicin—thyroid cancer	0.00377	0.00611	CcSEcCtD
Desogestrel—Weight decreased—Epirubicin—thyroid cancer	0.00375	0.00608	CcSEcCtD
Desogestrel—PGR—Generic Transcription Pathway—THRB—thyroid cancer	0.00371	0.00968	CbGpPWpGaD
Desogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—thyroid cancer	0.0036	0.00938	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—TPR—thyroid cancer	0.00357	0.00932	CbGpPWpGaD
Desogestrel—Weight increased—Doxorubicin—thyroid cancer	0.00349	0.00566	CcSEcCtD
Desogestrel—Weight decreased—Doxorubicin—thyroid cancer	0.00347	0.00562	CcSEcCtD
Desogestrel—PGR—Validated nuclear estrogen receptor alpha network—CCND1—thyroid cancer	0.00342	0.00891	CbGpPWpGaD
Desogestrel—ESR1—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00338	0.00882	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—TERT—thyroid cancer	0.00331	0.00862	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—NRG1—thyroid cancer	0.0033	0.00859	CbGpPWpGaD
Desogestrel—Erythema multiforme—Epirubicin—thyroid cancer	0.00313	0.00508	CcSEcCtD
Desogestrel—Eye disorder—Epirubicin—thyroid cancer	0.0031	0.00502	CcSEcCtD
Desogestrel—ESR1—AP-1 transcription factor network—HIF1A—thyroid cancer	0.00309	0.00805	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00301	0.00786	CbGpPWpGaD
Desogestrel—Immune system disorder—Epirubicin—thyroid cancer	0.00299	0.00486	CcSEcCtD
Desogestrel—Alopecia—Epirubicin—thyroid cancer	0.00293	0.00475	CcSEcCtD
Desogestrel—Mental disorder—Epirubicin—thyroid cancer	0.0029	0.00471	CcSEcCtD
Desogestrel—Erythema multiforme—Doxorubicin—thyroid cancer	0.0029	0.0047	CcSEcCtD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.00289	0.00754	CbGpPWpGaD
Desogestrel—Malnutrition—Epirubicin—thyroid cancer	0.00289	0.00468	CcSEcCtD
Desogestrel—Eye disorder—Doxorubicin—thyroid cancer	0.00287	0.00465	CcSEcCtD
Desogestrel—ESR1—FOXM1 transcription factor network—CCND1—thyroid cancer	0.00281	0.00732	CbGpPWpGaD
Desogestrel—Immune system disorder—Doxorubicin—thyroid cancer	0.00277	0.00449	CcSEcCtD
Desogestrel—Alopecia—Doxorubicin—thyroid cancer	0.00271	0.0044	CcSEcCtD
Desogestrel—Mental disorder—Doxorubicin—thyroid cancer	0.00269	0.00436	CcSEcCtD
Desogestrel—Malnutrition—Doxorubicin—thyroid cancer	0.00267	0.00433	CcSEcCtD
Desogestrel—ESR1—Estrogen signaling pathway—AKT1—thyroid cancer	0.00253	0.0066	CbGpPWpGaD
Desogestrel—Hypertension—Epirubicin—thyroid cancer	0.00249	0.00404	CcSEcCtD
Desogestrel—PGR—Gene Expression—TRIM33—thyroid cancer	0.00247	0.00645	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—NRAS—thyroid cancer	0.00247	0.00643	CbGpPWpGaD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00244	0.00396	CcSEcCtD
Desogestrel—ESR1—Signaling by ERBB4—CDK1—thyroid cancer	0.00241	0.00628	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—MEN1—thyroid cancer	0.00236	0.00615	CbGpPWpGaD
Desogestrel—Nervous system disorder—Epirubicin—thyroid cancer	0.00231	0.00375	CcSEcCtD
Desogestrel—Hypertension—Doxorubicin—thyroid cancer	0.0023	0.00374	CcSEcCtD
Desogestrel—Skin disorder—Epirubicin—thyroid cancer	0.00229	0.00371	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00226	0.00366	CcSEcCtD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.00225	0.00586	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—THRB—thyroid cancer	0.00218	0.00568	CbGpPWpGaD
Desogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—thyroid cancer	0.00214	0.00558	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—CCND1—thyroid cancer	0.00214	0.00558	CbGpPWpGaD
Desogestrel—Nervous system disorder—Doxorubicin—thyroid cancer	0.00214	0.00347	CcSEcCtD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—KRAS—thyroid cancer	0.00212	0.00553	CbGpPWpGaD
Desogestrel—Skin disorder—Doxorubicin—thyroid cancer	0.00212	0.00343	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00203	0.0033	CcSEcCtD
Desogestrel—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—thyroid cancer	0.00201	0.00523	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.00194	0.00505	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—NRG1—thyroid cancer	0.00193	0.00504	CbGpPWpGaD
Desogestrel—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00193	0.00312	CcSEcCtD
Desogestrel—ESR1—Regulation of Telomerase—CCND1—thyroid cancer	0.00191	0.00498	CbGpPWpGaD
Desogestrel—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00188	0.00305	CcSEcCtD
Desogestrel—Urticaria—Epirubicin—thyroid cancer	0.00187	0.00303	CcSEcCtD
Desogestrel—ESR1—AP-1 transcription factor network—CCND1—thyroid cancer	0.00187	0.00487	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.00186	0.00486	CbGpPWpGaD
Desogestrel—Abdominal pain—Epirubicin—thyroid cancer	0.00186	0.00302	CcSEcCtD
Desogestrel—ESR1—LKB1 signaling events—TP53—thyroid cancer	0.00182	0.00473	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—HRAS—thyroid cancer	0.0018	0.0047	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—PTEN—thyroid cancer	0.0018	0.0047	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—THRB—thyroid cancer	0.00179	0.00466	CbGpPWpGaD
Desogestrel—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00178	0.00289	CcSEcCtD
Desogestrel—ESR1—Leptin signaling pathway—CCND1—thyroid cancer	0.00177	0.00461	CbGpPWpGaD
Desogestrel—Hypersensitivity—Epirubicin—thyroid cancer	0.00173	0.00281	CcSEcCtD
Desogestrel—Urticaria—Doxorubicin—thyroid cancer	0.00173	0.00281	CcSEcCtD
Desogestrel—Abdominal pain—Doxorubicin—thyroid cancer	0.00172	0.00279	CcSEcCtD
Desogestrel—PGR—Signaling Pathways—CALCB—thyroid cancer	0.0017	0.00442	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—PTEN—thyroid cancer	0.00165	0.0043	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.00165	0.00429	CbGpPWpGaD
Desogestrel—Diarrhoea—Epirubicin—thyroid cancer	0.00161	0.00261	CcSEcCtD
Desogestrel—PGR—Signaling Pathways—TRIM33—thyroid cancer	0.00161	0.00419	CbGpPWpGaD
Desogestrel—Hypersensitivity—Doxorubicin—thyroid cancer	0.00161	0.0026	CcSEcCtD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—AKT1—thyroid cancer	0.00159	0.00415	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—RXRA—thyroid cancer	0.00158	0.00411	CbGpPWpGaD
Desogestrel—Vomiting—Epirubicin—thyroid cancer	0.0015	0.00243	CcSEcCtD
Desogestrel—Diarrhoea—Doxorubicin—thyroid cancer	0.00149	0.00242	CcSEcCtD
Desogestrel—Rash—Epirubicin—thyroid cancer	0.00148	0.00241	CcSEcCtD
Desogestrel—Dermatitis—Epirubicin—thyroid cancer	0.00148	0.00241	CcSEcCtD
Desogestrel—Headache—Epirubicin—thyroid cancer	0.00148	0.00239	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—NRAS—thyroid cancer	0.00147	0.00384	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—TRIM33—thyroid cancer	0.00145	0.00378	CbGpPWpGaD
Desogestrel—Nausea—Epirubicin—thyroid cancer	0.0014	0.00227	CcSEcCtD
Desogestrel—Vomiting—Doxorubicin—thyroid cancer	0.00139	0.00225	CcSEcCtD
Desogestrel—ESR1—Generic Transcription Pathway—MEN1—thyroid cancer	0.00138	0.00361	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.00138	0.00361	CbGpPWpGaD
Desogestrel—Rash—Doxorubicin—thyroid cancer	0.00137	0.00223	CcSEcCtD
Desogestrel—Dermatitis—Doxorubicin—thyroid cancer	0.00137	0.00223	CcSEcCtD
Desogestrel—Headache—Doxorubicin—thyroid cancer	0.00136	0.00221	CcSEcCtD
Desogestrel—Nausea—Doxorubicin—thyroid cancer	0.00129	0.0021	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—KRAS—thyroid cancer	0.00127	0.00331	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—TP53—thyroid cancer	0.00123	0.00321	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—TPR—thyroid cancer	0.00121	0.00315	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—MEN1—thyroid cancer	0.00113	0.00296	CbGpPWpGaD
Desogestrel—ESR1—Leptin signaling pathway—HRAS—thyroid cancer	0.00111	0.0029	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—HRAS—thyroid cancer	0.00108	0.00281	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TCF7L1—thyroid cancer	0.00107	0.0028	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—AKT1—thyroid cancer	0.00106	0.00277	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—THRB—thyroid cancer	0.00105	0.00273	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.00101	0.00263	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—PPARG—thyroid cancer	0.000996	0.0026	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CALCB—thyroid cancer	0.000995	0.00259	CbGpPWpGaD
Desogestrel—ESR1—Leptin signaling pathway—AKT1—thyroid cancer	0.000982	0.00256	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.000974	0.00254	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—PTEN—thyroid cancer	0.000969	0.00253	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—AKT1—thyroid cancer	0.000951	0.00248	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TRIM33—thyroid cancer	0.000943	0.00246	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—RXRA—thyroid cancer	0.000926	0.00241	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000925	0.00241	CbGpPWpGaD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.000924	0.00241	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—NRAS—thyroid cancer	0.000864	0.00225	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000836	0.00218	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000807	0.0021	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TSHR—thyroid cancer	0.000785	0.00205	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PRKAR1A—thyroid cancer	0.000772	0.00201	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—RXRA—thyroid cancer	0.000759	0.00198	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.000748	0.00195	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—KRAS—thyroid cancer	0.000744	0.00194	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MEN1—thyroid cancer	0.000738	0.00192	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—TPR—thyroid cancer	0.000708	0.00185	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PTCH1—thyroid cancer	0.000667	0.00174	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—MEN1—thyroid cancer	0.000666	0.00174	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.000665	0.00173	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—HRAS—thyroid cancer	0.000632	0.00165	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TCF7L1—thyroid cancer	0.000629	0.00164	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.00062	0.00162	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—SST—thyroid cancer	0.00061	0.00159	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CALCA—thyroid cancer	0.000588	0.00153	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—PPARG—thyroid cancer	0.000584	0.00152	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	0.000561	0.00146	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—AKT1—thyroid cancer	0.000558	0.00146	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000551	0.00144	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CDK1—thyroid cancer	0.000532	0.00139	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—PPARG—thyroid cancer	0.000479	0.00125	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000465	0.00121	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TSHR—thyroid cancer	0.000461	0.0012	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PRKAR1A—thyroid cancer	0.000453	0.00118	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—RXRA—thyroid cancer	0.000446	0.00116	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MEN1—thyroid cancer	0.000433	0.00113	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—NRG1—thyroid cancer	0.000427	0.00111	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PTCH1—thyroid cancer	0.000392	0.00102	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TERT—thyroid cancer	0.000383	0.000999	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—HIF1A—thyroid cancer	0.000367	0.000956	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—SST—thyroid cancer	0.000358	0.000934	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CALCA—thyroid cancer	0.000345	0.000899	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CDK1—thyroid cancer	0.000312	0.000814	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—BRAF—thyroid cancer	0.000304	0.000792	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—PPARG—thyroid cancer	0.000281	0.000734	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NRG1—thyroid cancer	0.000251	0.000653	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TERT—thyroid cancer	0.000225	0.000587	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CCND1—thyroid cancer	0.000222	0.000578	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HIF1A—thyroid cancer	0.000215	0.000561	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PTEN—thyroid cancer	0.000214	0.000558	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—NRAS—thyroid cancer	0.000191	0.000497	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—AKT1—thyroid cancer	0.00019	0.000494	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—BRAF—thyroid cancer	0.000178	0.000465	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—KRAS—thyroid cancer	0.000164	0.000428	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TP53—thyroid cancer	0.000146	0.000381	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—HRAS—thyroid cancer	0.00014	0.000364	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CCND1—thyroid cancer	0.00013	0.000339	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PTEN—thyroid cancer	0.000125	0.000327	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—AKT1—thyroid cancer	0.000123	0.000321	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NRAS—thyroid cancer	0.000112	0.000292	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—AKT1—thyroid cancer	0.000111	0.00029	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—KRAS—thyroid cancer	9.64e-05	0.000251	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TP53—thyroid cancer	8.56e-05	0.000223	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HRAS—thyroid cancer	8.19e-05	0.000214	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—AKT1—thyroid cancer	7.23e-05	0.000189	CbGpPWpGaD
